Mineralys Therapeutics
MLYS
MLYS
190 hedge funds and large institutions have $3.01B invested in Mineralys Therapeutics in 2025 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 67 increasing their positions, 63 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
16% more funds holding
Funds holding: 164 → 190 (+26)
6% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 63
87% less call options, than puts
Call options by funds: $2.54M | Put options by funds: $19M
Holders
190
Holding in Top 10
14
Calls
$2.54M
Puts
$19M
Top Buyers
| 1 | +$77.8M | |
| 2 | +$68.2M | |
| 3 | +$67M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$63.4M |
| 5 |
Holocene Advisors
New York
|
+$45.7M |
Top Sellers
| 1 | -$45.5M | |
| 2 | -$38.5M | |
| 3 | -$32.6M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$19.2M |
| 5 |
SC
Stempoint Capital
New York
|
-$18M |
